Helio talked with Dr. Gretchen White about her team's study examining real-world data for weight loss in patients with T2 diabetes and taking a GLP-1 agonist. "Data from clinical trials have been very promising on this front, but it’s reassuring to see that these medications are also useful in clinical settings that aren’t as highly controlled as clinical trials," Dr. White said. The paper was recently published by Obesity. Co-authors include Drs. David Rometo, Jon Arnold, Mary Korytkowski, and CP3's Dr. Jing Luo & Ingrid Shu.